how safe are glp-1 drugs Medications Infographic How safe are GLP-1s? -

Cost and patient reluctance toward injectables pose significant restraints to market growth

Some plans may cover GLP-1 drugs for diabetes but not for weight loss

In doing so, we advocate for a paradigm that moves beyond traditional indications, embracing the full spectrum of GLP-1R agonists in areas such as primary prevention, microvascular protection, and metabolic liver disease, and metabolic disorders that include cardio-kidney-metabolic (CKM) syndromea systemic disorder characterized by interrelated metabolic, renal, and cardiovascular dysfunction and a broader cardio-renal-metabolic axis that includes central obesity, insulin resistance, dyslipidemia, hypertension, and pre-diabetic states

Zepbound, Wegovy, and Beyond: Which is Right for You

A trial of more than 17,000 people found semaglutide (the active drug in Ozempic/Wegovy) cut the risk of serious heart attacks and strokes by 20%, even in people without diabetes

Data related to demographic information, such as authors, year of study, country, study population, study design, and primary outcomes, such as colorectal cancer risk, were extracted (Table 1)